EarningsQ1 2024 Earnings Report

Nektar Therapeutics (ITH0) Q1 2024 Earnings Report

1 Followers

DE:ITH0 Q1 2024 EPS Results

Actual EPS-€2.54

Consensus EPS-€2.54

Beat/MissMet expectations

One Year Ago EPS-€9.74

Actual Revenue€19.25M

Expected Revenue€13.65M

Beat/MissBeat by +€5.60M

YoY Revenue Growth+0.21%

QuarterQ1 2024

Date05/09/2024

TimeAfter Close

Conference CallThursday, May 9, 2024

DE:ITH0 Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:ITH0 Q1 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.87 / -	-1.664	―
Aug 13, 2026	2026 (Q2)	-1.75 / -1.09	-2.625	58.31% (+1.53)
May 07, 2026	2026 (Q1)	-1.41 / -1.62	-3.203	49.44% (+1.58)
Mar 12, 2026	2025 (Q4)	-2.20 / -1.58	0.4	-495.56% (-1.98)
Nov 06, 2025	2025 (Q3)	-2.39 / -1.66	-2.402	30.74% (+0.74)
Aug 07, 2025	2025 (Q2)	-2.69 / -2.62	-3.337	21.33% (+0.71)
May 08, 2025	2025 (Q1)	-2.28 / -3.20	-2.536	-26.32% (-0.67)
Mar 12, 2025	2024 (Q4)	-1.81 / 0.40	-2.936	113.64% (+3.34)
Nov 07, 2024	2024 (Q3)	-2.66 / -2.40	-3.203	25.00% (+0.80)
Aug 08, 2024	2024 (Q2)	-2.47 / -3.34	-3.603	7.41% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed